Women's Health
Gynaecology Basket

Women's health and hormone basket for oral contraceptives, emergency contraception, endometriosis and hormone therapy opportunities.

DrospirenoneDesogestrelDienogestLevonorgestrelNorgestrelGestodeneEthinyl EstradiolEstradiol ValerateEstradiol CypionateEstradiol HemihydrateTiboloneUlipristal Acetate

Every decade brings a different hormonal question.

Women's health is not a single condition — it is a lifelong hormonal narrative. From the first menstrual cycle to the last, the central characters are oestrogen and progesterone. When they are balanced, life proceeds. When they shift — through contraceptive choice, endometriosis, pregnancy, or menopause — clinical intervention becomes a question of quality of life.

Our gynaecology portfolio spans the full arc of that journey: contraception, disorder management, fertility support, and hormonal restoration.

Phase 1

Reproductive Years

Contraception, cycle regulation & hormonal balance

The first question is always hormonal. Whether managing an irregular cycle, preventing pregnancy, or treating PCOS — oestrogen and progestogen combinations form the pharmacological foundation of women's reproductive health. The science is decades deep; the art is in choosing the right combination for the right patient.

Portfolio Molecules

Ethinylestradiol + Levonorgestrel

Combined OCP

Ethinylestradiol + Cyproterone

OCP / PCOS / anti-androgen

Ethinylestradiol + Dienogest

Combined OCP / endometriosis

Levonorgestrel

Emergency & regular contraception

Phase 2

Endometriosis & Gynaecological Disorders

A condition affecting 1 in 10 women — still widely under-diagnosed

Endometriosis takes an average of 7–10 years to diagnose. By the time a woman has a name for her pain, her quality of life has often been compromised for nearly a decade. Modern progestogen therapy — particularly with high-selectivity molecules — has transformed the management approach.

Portfolio Molecules

Dienogest

High-specificity progestogen for endometriosis

Norethisterone

Endometriosis / menstrual disorders

Medroxyprogesterone

Endometriosis / HRT

Dydrogesterone

Luteal support / recurrent miscarriage

Phase 3

Perimenopause & Beyond

Hormonal transition — managing the continuum

Menopause is not a disease. But the hormonal transition surrounding it — the vasomotor symptoms, the urogenital changes, the mood disruption — deserves the same rigorous clinical attention as any chronic condition. Hormone replacement therapy, when prescribed thoughtfully, is one of the most evidence-backed interventions in medicine.

Portfolio Molecules

Estradiol

HRT — vasomotor & urogenital symptoms

Progesterone

Endometrial protection in HRT

Dydrogesterone

HRT progestogen component

Medroxyprogesterone

Systemic HRT

1 in 10

Women affected by endometriosis globally

₹1,632 Mn

SSPL gynaecology portfolio — MAT Mar 2026

3 phases

Reproductive · Disorders · Perimenopause